oxonic acid has been researched along with Adenocarcinoma, Bronchiolo-Alveolar in 3 studies
Oxonic Acid: Antagonist of urate oxidase.
Adenocarcinoma, Bronchiolo-Alveolar: A carcinoma derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, H | 1 |
| Nishio, M | 1 |
| Murakami, H | 1 |
| Ohyanagi, F | 1 |
| Kozuka, T | 1 |
| Ishikura, S | 1 |
| Naito, T | 1 |
| Kaira, K | 1 |
| Takahashi, T | 1 |
| Horiike, A | 1 |
| Nishimura, T | 1 |
| Yamamoto, N | 1 |
| Kobayashi, S | 1 |
| Fujino, N | 1 |
| Suzuki, S | 1 |
| Yanai, M | 1 |
| Arai, W | 1 |
| Hosoya, Y | 1 |
| Hyodo, M | 1 |
| Yokoyama, T | 1 |
| Saito, S | 1 |
| Kurasina, K | 1 |
| Aoki, T | 1 |
| Yasuda, Y | 1 |
| Nagai, H | 1 |
| Tamada, K | 1 |
1 trial available for oxonic acid and Adenocarcinoma, Bronchiolo-Alveolar
| Article | Year |
|---|---|
Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Antineoplastic Combined Chemothera | 2013 |
2 other studies available for oxonic acid and Adenocarcinoma, Bronchiolo-Alveolar
| Article | Year |
|---|---|
Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine).
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung | 2009 |
[Every-other-day TS-1 administration for recurrent or non-curative advanced gastric carcinoma].
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Antimetabolites, Antineoplastic; Carcinoma, Signet Ring C | 2002 |